Dermatology and therapy
Oral JΑΚ Inhibitors in Vitiligo Treatment.
Angeliki Panagopoulou, Elena Sotiriou, Ilias Papadimitriou, Anastasios Pavlidis, Katerina Bakirtzi, Aikaterini Tsentemeidou, Michael Arabatzis, Efstratios Vakirlis, Dimitra Kiritsi
Published: 202610.1007/s13555-026-01652-x
Abstract
INTRODUCTION: Vitiligo is an acquired disorder of skin pigmentation characterized by impaired melanocyte function and the appearance of well-outlined, white skin spots. Worldwide the incidence ranges between 0.5% and 2%. It has a negative impact on t…
Preview only. Read the full abstract at the source